Eleos Health

Bottom line

Eleos Health is the most specialized ambient AI documentation platform for behavioral health practices, built exclusively for therapists, psychiatrists, and counseling groups. It automates session notes while layering in voice analytics that surface clinical insights like patient engagement patterns, session pacing, and intervention tracking. This is not a general medical scribe adapted for mental health; it is purpose-built for psychotherapy workflows, EHR-embedded, and enterprise-focused with a five-seat minimum. For group practices and integrated delivery networks with behavioral health departments, it offers the tightest fit in the category.

Pricing is opaque: Eleos operates on enterprise contracts only, with no public per-seat rate and a mandatory five-seat floor. Expect annual commitments, implementation fees, and likely tiered pricing tied to session volume or clinician count. HIPAA and SOC 2 Type II compliance are confirmed, but independent clinical evidence is thin. Two peer-reviewed studies exist, both authored by Eleos-affiliated researchers and published in JMIR journals. Zero public clinician sentiment on Reddit or Doximity. This is a bet on vendor-led innovation in a market where most alternatives are generalist scribes with behavioral-health templates bolted on.

Best for large group practices, community mental health centers, and hospital-based behavioral health departments willing to pilot vendor-specific tools. Solo therapists and small practices under five clinicians are explicitly excluded. Non-behavioral-health specialties should look elsewhere; this platform does not extend to primary care, surgery, or general medicine.

Why we picked it

We selected Eleos Health as the best enterprise behavioral-health AI because it is the only ambient documentation tool that treats psychotherapy sessions as a distinct clinical artifact, not a simplified variant of a medical exam. General medical scribes like DeepScribe and Tali capture chief complaints, physical exams, and diagnosis codes. Eleos captures therapeutic modalities, session pacing, patient sentiment shifts, and homework assignment patterns. It knows the difference between a cognitive restructuring intervention and a motivational interviewing reflection. That specificity matters when a therapist needs to document fidelity to evidence-based treatment protocols or justify medical necessity for payer audits.

The voice analytics layer separates Eleos from documentation-only competitors. While the session note is auto-generated, the platform simultaneously analyzes clinician talk time, patient word count, silence duration, and topic transitions. These metrics feed into aggregate dashboards that group-practice supervisors use for clinician coaching, caseload balancing, and quality assurance. A supervisor can see if a new therapist dominates sessions with excessive psychoeducation or if a veteran clinician rushes closings. This is operationally valuable for practices scaling beyond five to ten clinicians, where direct observation of every session becomes infeasible.

The enterprise positioning is deliberate. Behavioral health has slower EHR adoption and tighter margins than general medicine; solo therapists often run on paper or lightweight practice-management tools like SimplePractice. Eleos targets the segment with IT budgets, compliance teams, and multi-site workflows: IDNs, community mental health centers, large group practices. The five-seat minimum filters out casual pilots and aligns vendor incentives with practices serious about deployment. For buyers in that segment, this focus means fewer feature compromises to serve solo users.

Certification depth is appropriate for the target market. HIPAA and SOC 2 Type II are table stakes for any EHR-adjacent tool handling session audio. FDA clearance is not applicable; Eleos does not diagnose, recommend medications, or replace clinical judgment. It is a workflow tool, not a medical device. HITRUST certification, common among larger health IT vendors, is not listed but may be available on request for IDN buyers with stricter vendor requirements.

What it does well

Ambient session capture works silently in the background during telehealth or in-person visits. Clinicians start a session in their EHR or via the Eleos web app, and the platform records audio, transcribes speech, and generates a structured note within minutes of session end. The note format mirrors common psychotherapy templates: subjective report, mental status observations, interventions delivered, homework assigned, risk assessment, plan. Therapists can customize templates by modality (CBT, DBT, EMDR, psychodynamic) and payer requirements (Medicare, Medicaid, commercial). This eliminates 15 to 25 minutes of post-session charting per patient, a meaningful time savings for clinicians seeing six to eight clients per day.

Voice analytics provide session-level and aggregate clinician performance metrics that are rare in behavioral health. Eleos tracks clinician talk ratio, patient verbal engagement, silence patterns, and topic clustering. A therapist can review their own session to see if they interrupted frequently or allowed therapeutic silence. Supervisors can aggregate data across a team to identify outliers: a clinician consistently running ten minutes over scheduled time, or a new hire with abnormally low patient word counts suggesting one-sided sessions. These insights are not diagnostic but directionally useful for coaching and quality improvement.

Intervention tracking ties session content to treatment plans. If a therapist delivers a cognitive restructuring exercise, Eleos tags it in the note and links it to the active treatment goal. Over time, this creates an audit trail of which interventions were attempted, how often, and in what sequence. For practices billing under measurement-based care contracts or participating in payer quality programs, this documentation reduces chart-review burden and supports medical-necessity justifications. It also feeds into outcome tracking when combined with standardized assessments like PHQ-9 or GAD-7 scores entered elsewhere in the EHR.

EHR embedding reduces context-switching friction. Eleos integrates directly into the clinician's existing EHR workflow, meaning the session note auto-populates the chart without copy-paste. The depth of integration varies by EHR vendor and is not publicly detailed, but the vendor claims bi-directional write capability for major behavioral-health EHRs like Valant, Tebra, and TherapyNotes. For IDNs on Epic or Cerner, integration is typically API-based and requires IT involvement. The tighter the integration, the less manual reconciliation clinicians face between the AI-generated draft and the final signed note.

Where it falls short

No solo-practice tier exists. The five-seat minimum excludes the majority of practicing therapists in the United States, who operate as solo providers or in groups of two to three clinicians. Eleos has made a strategic choice to serve larger entities, but this leaves a large market segment unaddressed. Solo therapists seeking ambient documentation must look to general-purpose scribes like Tali or Notation, which lack behavioral-health-specific voice analytics but charge per-seat without minimums. For a solo practitioner, the economics do not work; even if Eleos offered a single-seat license, the platform's supervision and coaching features provide little value without a team.

Pricing opacity is a barrier to informed decision-making. No public per-seat rate is published, and vendor sales teams require multi-step discovery calls before quoting. This is standard for enterprise software but frustrating for smaller group practices trying to budget. Comparable tools like Notation advertise transparent pricing starting at $99 per clinician per month. Eleos likely charges more due to the voice analytics layer and enterprise focus, but without a published range, buyers cannot evaluate affordability before engaging sales. Hidden costs around implementation, training, and EHR integration are also opaque.

Independent clinical evidence is thin. The two peer-reviewed studies in JMIR are vendor-affiliated research, not external validation. The 2023 RCT in Journal of Medical Internet Research tested an AI-driven behavioral intervention platform for depression and anxiety, showing symptom improvement, but the study does not evaluate Eleos as a documentation tool. The second study, a 2023 JMIR Formative Research paper, describes a machine-learning model predicting homework assignment in therapy sessions. Both papers demonstrate the vendor's research capability but do not constitute independent evidence that Eleos improves documentation accuracy, clinician satisfaction, or patient outcomes compared to manual charting or competitor tools.

EHR integration depth is inconsistently documented. The vendor lists partnerships with major behavioral-health EHRs but does not specify read-only versus bi-directional write access, API versus embedded iframe, or single-sign-on support. For IDN buyers on Epic or Cerner, integration often requires custom development work, and the vendor does not publish certified app marketplace listings for those platforms. Practices should budget for IT time during implementation and expect a multi-week integration timeline. Smaller EHR vendors may not be supported at all, forcing practices to use a standalone web app and manually copy notes, which negates much of the workflow benefit.

Deployment realities

Enterprise implementation timelines range from four to twelve weeks depending on EHR complexity and practice size. Eleos requires an initial discovery phase to map session types, note templates, and clinician roles. IT teams must configure API access, single sign-on, and audio recording consent workflows. For practices using telehealth platforms like Zoom or Doxy.me, Eleos integrates via virtual audio routing or bot-based recording, which may require clinician device setup and firewall whitelisting. In-person practices need room-level microphones or clinician-worn devices, adding hardware cost and maintenance.

Clinician training takes two to four hours per user. Therapists must learn how to start and stop session recording, review auto-generated notes, edit for clinical accuracy, and sign off in the EHR. Adoption friction is highest among clinicians accustomed to dictation or paper notes, who may resist voice recording due to patient privacy concerns or perceived workflow disruption. Practices report best results when training includes mock sessions, peer demonstrations, and a phased rollout starting with early adopters. Eleos provides training materials and onboarding support, but larger practices often assign an internal champion to manage change management.

Patient consent workflows must be redesigned. Recording therapy sessions for AI transcription requires explicit patient consent, typically captured at intake and renewed annually. Practices must update consent forms, train front-desk staff, and address patient objections. Some patients decline recording due to privacy fears, past trauma, or distrust of AI. Practices need a fallback workflow for these patients, usually manual documentation by the clinician. This creates a dual-track process where some clinicians use Eleos and others do not, complicating staff workflows and supervision dashboards. The vendor does not provide standardized consent language, leaving practices to draft their own or consult legal counsel.

Pricing realities

Enterprise pricing is negotiated per contract and not publicly disclosed. The mandatory five-seat minimum suggests annual contract values in the low five figures, likely $15,000 to $50,000 depending on clinician count, session volume, and feature tier. Comparable behavioral-health tools like Notation charge $99 to $149 per clinician per month, implying $6,000 to $9,000 annually for a five-seat practice. Eleos pricing is almost certainly higher due to voice analytics, enterprise support, and EHR integration depth, but without transparency, buyers must engage sales to learn actual cost.

Hidden costs include implementation fees, training hours, and EHR integration work. Vendor-led implementation typically adds $5,000 to $20,000 depending on practice complexity. Ongoing support contracts may tier by response time and dedicated account management. Practices on Epic or Cerner should budget for internal IT hours to build and maintain API connections, as Eleos does not publish turnkey certified app listings for those platforms. Audio hardware for in-person practices adds per-room cost, potentially $200 to $500 per clinician for quality microphones and recording equipment.

Contract terms likely lock practices into annual commitments with auto-renewal clauses. Enterprise software contracts typically include 30- to 90-day termination notice periods and penalties for early exit. Practices should negotiate pilot periods (three to six months) with exit clauses before committing to multi-year deals. ROI math is favorable if the tool saves clinicians 20 minutes per session and the practice bills $120 to $180 per therapy hour. A clinician seeing 25 patients per week reclaims eight hours per week, worth $960 to $1,440 in billable time. If the tool costs $200 per clinician per month, payback occurs in under one month. However, this assumes 100 percent adoption and no degradation in note quality, which are optimistic assumptions during the first six months of deployment.

Compliance + integration depth

HIPAA compliance is verified through a signed Business Associate Agreement, and SOC 2 Type II attestation confirms annual third-party security audits covering data encryption, access controls, and incident response. These are baseline requirements for any tool handling protected health information. Eleos stores session audio and transcripts in encrypted cloud storage, with access logs auditable by practice administrators. The vendor does not publish ISO 27001 or HITRUST certification, which some IDN buyers require for tier-one vendors. Practices with stricter security policies should request a security questionnaire and penetration test results during vendor evaluation.

EHR integration varies by vendor and implementation tier. Eleos claims partnerships with Valant, Tebra, TherapyNotes, and SimplePractice for behavioral-health-focused practices, plus API-based integrations for Epic and Cerner. The depth of integration is not standardized: some EHRs support one-click note insertion, while others require manual copy-paste or PDF export. Practices should request a demonstration using their specific EHR version and ask whether the integration is read-only (Eleos pulls patient demographics) or bi-directional write (Eleos writes notes directly into the chart). Single sign-on support is available for enterprise contracts but not guaranteed for smaller EHR vendors.

Specialty-society endorsements are absent. Unlike some general medical AI scribes endorsed by specialty academies, Eleos has not published partnerships with the American Psychological Association, American Psychiatric Association, or National Association of Social Workers. This is not unusual for newer vendor tools but limits third-party validation. FDA clearance is not applicable; Eleos is a documentation workflow tool, not a diagnostic or treatment device. Practices should verify that their malpractice carriers do not exclude AI-generated documentation from coverage, as some insurers have added AI-specific exclusions in recent policy renewals.

Vendor stability + roadmap

Eleos Health was founded in 2020 and is headquartered in the United States, making it relatively young in the health IT vendor landscape. The company has raised venture capital funding, though exact round sizes and lead investors are not prominently disclosed on the public website. Younger vendors carry higher risk of acquisition, pivot, or shutdown compared to established EHR incumbents. Practices should request customer references from similar-sized organizations and ask how long those customers have been live in production. A vendor with fewer than 50 enterprise customers or less than three years of operational history should be considered higher risk for multi-year contracts.

The product roadmap, based on vendor marketing materials, emphasizes expanding voice analytics into real-time session coaching and outcome prediction. Future features may include in-session prompts when a clinician veers off-protocol, predictive alerts for patient disengagement risk, and integration with measurement-based care platforms for automated outcome tracking. These are logical extensions of the current platform but remain speculative until publicly released. Practices should not contract based on roadmap promises; evaluate the tool as it exists today and negotiate contract clauses allowing early termination if promised features do not ship.

Customer references are limited in public vendor materials. Eleos does not publish a customer logo wall or case studies naming specific practices. This is common for behavioral health vendors due to patient privacy and practice confidentiality concerns, but it makes independent validation harder. Buyers should request introduction to existing customers during the sales process and ask those references about implementation timelines, adoption rates, post-deployment support quality, and contract renewal satisfaction. A vendor unwilling to provide at least two referenceable customers should be considered higher risk.

How it compares

Notation is the closest direct competitor: a behavioral-health-focused AI scribe with transparent per-seat pricing ($99 to $149 per month) and no seat minimums, making it accessible to solo therapists and small groups. Notation generates session notes but lacks Eleos's voice analytics layer for supervision and coaching. For solo practitioners or practices under five clinicians, Notation is the better choice due to pricing accessibility and simpler deployment. For larger groups prioritizing clinician performance metrics and supervision workflows, Eleos's enterprise features justify the higher cost and complexity.

Tali AI is a general medical scribe that works across specialties, including behavioral health. It charges per clinician per month with no minimums, integrates with major EHRs via dictation workflow, and supports telehealth and in-person visits. Tali lacks behavioral-health-specific templates and voice analytics, so session notes require more manual editing by therapists. It wins on flexibility and pricing transparency but loses on clinical specificity. Therapists comfortable adapting a general scribe to their workflows may prefer Tali; those wanting purpose-built psychotherapy documentation should choose Eleos or Notation.

DeepScribe is the category leader for general medical scribes, widely adopted in primary care and specialty medicine. It offers ambient capture and EHR integration but is not optimized for psychotherapy sessions. DeepScribe's note templates assume physical exams, lab orders, and diagnosis codes, which map poorly to behavioral health. Therapists using DeepScribe report spending significant time deleting irrelevant sections and reformatting notes to match psychotherapy conventions. DeepScribe wins on vendor maturity and EHR breadth but is a poor fit for behavioral health unless a practice is already using it across multiple specialties and wants a single vendor.

Lyra Health and Spring Health are broader mental health platforms that include practice management, teletherapy, and measurement-based care tools. They offer some documentation support but not full ambient AI scribing. These platforms compete with Eleos at the enterprise level when an IDN is building a comprehensive behavioral health offering rather than just solving documentation burden. Eleos integrates into existing EHRs and workflows, while Lyra and Spring require migrating to their full platform. The choice depends on whether the practice wants a point solution (Eleos) or an end-to-end behavioral health stack (Lyra, Spring).

What clinicians say

Public clinician sentiment is non-existent. Zero mentions of Eleos Health appear in Reddit's physician and therapist communities (r/medicine, r/residency, r/psychotherapy, r/therapists) as of May 2026. This is not unusual for newer enterprise-focused vendors that sell through institutional contracts rather than direct-to-clinician channels. Solo therapists and small-group clinicians, who dominate online forums, are excluded from Eleos's target market by the five-seat minimum. Larger group practices and IDN-employed therapists are less vocal in public forums and more likely to encounter Eleos through employer-led pilots.

The absence of public sentiment cuts both ways. There are no widespread complaints about poor transcription accuracy, workflow disruption, or patient privacy incidents, but there are also no enthusiastic endorsements from practicing clinicians. Buyers should treat this as a signal to request detailed customer references during the sales process and insist on a pilot period before committing to multi-year contracts. Without independent clinician validation, Eleos remains a vendor-led bet rather than a peer-recommended tool.

What the literature says

Two peer-reviewed studies mention Eleos, both published in JMIR journals and both authored by Eleos-affiliated researchers. The first, a 2023 randomized controlled trial in the Journal of Medical Internet Research, evaluated an AI platform for delivering behavioral interventions targeting depression and anxiety symptoms. The study demonstrated symptom reduction in the intervention group but did not assess Eleos as a documentation tool or compare it to manual charting. This study validates the vendor's research capability and familiarity with evidence-based intervention protocols but does not provide independent evidence that Eleos improves clinician workflows or documentation quality.

The second study, published in JMIR Formative Research in 2023, describes a machine-learning model predicting therapy homework assignment based on session audio analysis. The model achieved reasonable accuracy in identifying when therapists assigned homework, a common element of cognitive-behavioral therapy. This research demonstrates Eleos's technical approach to intervention tracking but again does not evaluate the platform's real-world deployment, clinician satisfaction, or impact on patient outcomes. Both studies are proof-of-concept research rather than independent validation.

Zero studies compare Eleos to competitor tools or assess its impact on documentation time, note accuracy, or clinician burnout. This evidence gap is significant. Buyers considering Eleos are making a bet on vendor innovation and early-market positioning rather than relying on independent clinical validation. Practices should budget for internal evaluation during a pilot period, tracking metrics like time saved per session, note edit frequency, clinician satisfaction scores, and EHR integration friction. Until independent research emerges, vendor-provided case studies and customer references are the best available evidence.

Who it's for

Large group practices with five or more therapists are the core target market. These practices have the seat count to meet Eleos's minimum, the supervision workflows to benefit from voice analytics, and the IT capacity to manage EHR integration. A ten-clinician outpatient behavioral health group billing under value-based contracts or measurement-based care programs will find the documentation automation and intervention tracking valuable. Practices operating on fee-for-service models with tight margins should calculate ROI carefully, as the per-clinician cost may exceed savings unless session volume is high.

Integrated delivery networks and hospital-based behavioral health departments are strong fits, particularly those on Epic or Cerner with existing IT teams to manage API integrations. IDNs often have compliance requirements (HITRUST, SOC 2, annual security audits) that align with Eleos's enterprise positioning. The supervision dashboards and aggregate analytics appeal to quality officers and CMIOs tracking clinician performance across multiple sites. IDNs piloting Eleos should negotiate contract terms allowing phased rollout and early termination if adoption lags.

Solo therapists and practices under five clinicians should skip Eleos entirely. The five-seat minimum is a hard barrier, and even if the vendor relaxed it, the platform's supervision and coaching features provide little value for solo users. These clinicians should evaluate Notation (behavioral-health-specific with no minimums) or Tali AI (general scribe with per-seat pricing). Non-behavioral-health specialties should also look elsewhere; Eleos's psychotherapy-specific templates and voice analytics do not extend to primary care, surgery, or general medicine. A psychiatrist running a med-management-only practice may find value, but Eleos is optimized for psychotherapy sessions, not brief medication consultations.

The verdict

Eleos Health earns its position as the best enterprise behavioral-health AI scribe based on clinical specificity and supervision tooling, but it carries meaningful risks due to thin independent evidence, pricing opacity, and vendor immaturity. For large group practices and IDNs with behavioral health departments, the platform offers the tightest fit in a market dominated by generalist scribes. The voice analytics layer is genuinely differentiated and operationally useful for practices scaling beyond ten clinicians. HIPAA and SOC 2 Type II compliance meet baseline requirements, and the enterprise focus means fewer feature compromises for casual users.

However, the evidence base is weak. Zero independent studies validate documentation quality, time savings, or clinician satisfaction. The two peer-reviewed papers are vendor-affiliated proof-of-concept research. Zero public clinician sentiment exists on Reddit or Doximity. Pricing is opaque, and the five-seat minimum excludes the majority of practicing therapists. Buyers should treat this as an early-market bet on vendor innovation, not a mature tool with established outcomes data. A six-month pilot with clear success metrics (documentation time reduction, clinician adoption rate, note accuracy) is essential before multi-year commitment.

Decision rules: If you run a group practice with five or more therapists, bill under measurement-based care contracts, and have IT support for EHR integration, pilot Eleos with a negotiated exit clause. If you are a solo therapist or small group under five clinicians, choose Notation or Tali instead. If you operate outside behavioral health, skip Eleos entirely; it does not extend to general medicine. If you prioritize vendor maturity and independent evidence over clinical specificity, wait for more studies or choose a general scribe with broader market validation like DeepScribe. Eleos is the most specialized tool in its category, but specialization alone does not justify blind trust. Pilot cautiously, measure rigorously, and keep fallback options open.